PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
13-Oct-2025 ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States ONWARD Medical
13-Oct-2025 Lundbeck’s bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies Lundbeck
13-Oct-2025 CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Celebrates 50 Years of Global Pharmaceutical Excellence CHAPPER healthcare
13-Oct-2025 Countess of Chester Hospital NHS Foundation Trust Enhances Women’s Health Services with Ultrasound Upgrade Countess of Chester Hospital NHS
09-Oct-2025 New GCP Training Aligned with ICH E6(R3) from Pharma Lessons Pharma Lessons
09-Oct-2025 Orexa Announces Positive Interim Data for its Phase 2 Trial in the Prevention of Post-Operative Ileus Orexa
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedixTM (212Pb-DOTAMTATE)
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedixTM (
08-Oct-2025 Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 Portzamparc
08-Oct-2025 Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds Microbot Medical
07-Oct-2025 CluePoints Proven AI Innovation Earns Dual Recognition at SCDM and SCRIP Awards CluePoints
07-Oct-2025 TrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and Biotech TrialAssure
07-Oct-2025 Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer Theolytics
07-Oct-2025 Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025 Resolution Therapeutics
07-Oct-2025 appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate Bioxodes
06-Oct-2025 Transgene to Present New Immunological Data from Phase I Trial of Individualized Therapeutic Cancer Vaccine, TG4050, at SITC 2025 Transgene
06-Oct-2025 Promising results for Lead Biologics’ first-in-class checkpoint inhibitor published in Nature Cancer Lead Biologics
06-Oct-2025 Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA Hikma
06-Oct-2025 Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025 Enara Bio
06-Oct-2025 EG 427 Receives U.S. FDA Fast Track Designation for EG110A DNA Medicine in Neurogenic Bladder Patients EG 427